Lumen Technologies, Inc. (FRA:CYTH)

Lumen Technologies Statistics

Total Valuation

FRA:CYTH has a market cap or net worth of EUR 6.81 billion. The enterprise value is 21.93 billion.

Market Cap	6.81B
Enterprise Value	21.93B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.02B
Shares Outstanding	n/a
Shares Change (YoY)	+0.70%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	943.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.64
PB Ratio	-7.16
P/TBV Ratio	n/a
P/FCF Ratio	21.55
P/OCF Ratio	1.69
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.11, with an EV/FCF ratio of 69.41.

EV / Earnings	-14.81
EV / Sales	2.08
EV / EBITDA	9.11
EV / EBIT	n/a
EV / FCF	69.41

Financial Position

The company has a current ratio of 1.80

Current Ratio	1.80
Quick Ratio	0.64
Debt / Equity	n/a
Debt / EBITDA	6.63
Debt / FCF	50.73
Interest Coverage	-0.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-0.56%
Return on Invested Capital (ROIC)	-1.23%
Return on Capital Employed (ROCE)	-1.01%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	440,116
Profits Per Employee	-61,713
Employee Count	24,000
Asset Turnover	0.37
Inventory Turnover	42.69

Taxes

Income Tax	-832.11M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+43.67%
50-Day Moving Average	6.94
200-Day Moving Average	5.45
Relative Strength Index (RSI)	47.54
Average Volume (20 Days)	1,011

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.53

Income Statement

In the last 12 months, FRA:CYTH had revenue of EUR 10.56 billion and -1.48 billion in losses. Loss per share was -1.49.

Revenue	10.56B
Gross Profit	4.91B
Operating Income	-258.92M
Pretax Income	-2.31B
Net Income	-1.48B
EBITDA	2.08B
EBIT	-258.92M
Loss Per Share	-1.49

Balance Sheet

The company has 854.26 million in cash and 16.03 billion in debt, with a net cash position of -15.17 billion.

Cash & Cash Equivalents	854.26M
Total Debt	16.03B
Net Cash	-15.17B
Net Cash Per Share	n/a
Equity (Book Value)	-951.35M
Book Value Per Share	-0.93
Working Capital	3.00B

Cash Flow

In the last 12 months, operating cash flow was 4.04 billion and capital expenditures -3.72 billion, giving a free cash flow of 315.98 million.

Operating Cash Flow	4.04B
Capital Expenditures	-3.72B
Free Cash Flow	315.98M
FCF Per Share	n/a

Margins

Gross margin is 46.48%, with operating and profit margins of -2.45% and -14.02%.

Gross Margin	46.48%
Operating Margin	-2.45%
Pretax Margin	-21.90%
Profit Margin	-14.02%
EBITDA Margin	19.71%
EBIT Margin	-2.45%
FCF Margin	2.99%

Dividends & Yields

FRA:CYTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.70%
Shareholder Yield	-0.70%
Earnings Yield	-21.76%
FCF Yield	4.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 1, 1999. It was a forward split with a ratio of 1.5.

Last Split Date	Apr 1, 1999
Split Type	Forward
Split Ratio	1.5

Scores

FRA:CYTH has an Altman Z-Score of -0.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.25
Piotroski F-Score	3